CLINICAL STUDY FINDS FIBER AND NUTRIENT DRINK LOWERS TOTAL
CHOLESTEROL, LDL AND HOMOCYSTEINE

For Immediate Release Contact: Carol Walters
561/999-1960

Click here to download this press release (.PDF)

Orem, Utah (October 30, 2002) -- A new clinical study demonstrates that BIOS LIFE 2.
advanced fiber and nutrient drink is beneficial in lowering both total cholesterol and LDL
(“bad”) cholesterol levels when taken regularly along with a diet low in saturated fat and
cholesterol. In addition, the double-blind, peer-reviewed study shows that BIOS LIFE 2®
helps to reduce blood homocysteine levels. Reducing homocysteine levels is a welldocumented
method of lowering the risk of heart disease. BIOS LIFE 2® is marketed by
Unicity Network, international direct selling unit of Royal Numico, N.V., a world leader
in specialized nutrition.
The study, conducted at the prestigious Cleveland Clinic Foundation, Preventative
Cardiology Section, by Dennis L. Sprecher, M.D. and published in the September, 2002
issue of the journal Metabolism, compared fasting blood samples from approximately 100
subjects over an eight-week period. All study participants followed the National
Cholesterol Education Program (NCEP) Step 1 diet for six weeks prior to beginning the
study. Additionally, no concurrent lipid-lowering therapy or statin during the previous 30
days was permissible. Those participants who still had LDL cholesterol greater than 130
mg/dL following the six week diet program were included in the study and were required
to continue to follow the NCEP Step I diet for the duration of the investigation. Half of
the study participants were given twice-daily servings of BIOS LIFE 2®, and the other
half were given a placebo. Neither the researchers nor the participants were aware of
which substance any individual received.
The group receiving BIOS LIFE 2® had a significant reduction in LDL (“bad”)
cholesterol levels averaging 7.9 percent, while LDL increased an average of 2.4 percent
for the participants who received the placebo over the eight-week test period, for a 10.3
percent difference between the groups. Similarly, total cholesterol level for the BIOS
LIFE 2® group was significantly reduced by an average of 5.7 percent, while total
cholesterol levels for the participants receiving the placebo rose an average of 3.1
percent.

-Continue-
page 2

 
“Taking a fiber supplement is a fairly safe and easy way to help keep your cholesterol
under control,” Dr Sprecher said. “BIOS LIFE 2® makes getting enough fiber – along
with an important and efficacious combination of vitamins – convenient and available for
everyone.”
Dr, Sprecher also observed a significant reduction in blood homocysteine levels in the
BIOS LIFE 2® group. Homocysteine is an amino acid found in the blood, and high levels
of homocysteine have been associated with increased risk of vascular and heart disease.
In this study, homocysteine levels were found to drop significantly– an average of 11.2
percent – among the BIOS LIFE 2® group, while those in the placebo group dropped an
insignificant 2 percent.
“Such a product [as BIOS LIFE 2®],” the study concluded, “if taken regularly, could
reduce cardiovascular risk on a population basis and potentially decreases the need and/or
dose for lipid-lowering prescription drugs.”
Unicity International Inc., created by the unification of two of the direct-selling industry’s
highly successful companies –Rexall Showcase International and Enrich International -
markets scientifically-based and efficacious nutritional and personal care products
through a global network of Independent Business Owners. Its parent company, Royal
Numico, N.V., is a world leader in specialized nutrition, including infant formula, clinical
nutrition and nutritional supplements. Headquartered in The Netherlands, Royal Numico
operates in over 100 countries, has manufacturing facilities in more than 50 countries,
maintains research facilities in The Netherlands, Germany, the U.K., China, Australia and
the United States, and employs more than 28,5000 people worldwide.

Visit website at www.BL2.info

Click here to download this press release (.PDF)